Home
Meet MAP Patient Access

Meet MAP Patient Access

As of May 2024, we are delighted that AxTalis and MAP have joined forces to create a new group focussing on accelerating patient access across European markets.

Our expert team offer a broad range of specialist support. We help clients navigate the complexities of market access in the UK and Europe.

The Market Access Specialists for innovative technologies

Bringing your treatments to patients can be a long and complicated journey with significant financial investment. This is especially challenging for innovative technologies. Our expertise gives your products the best chance of reaching patients sooner. MAP understands the challenges facing BioPharma companies in bringing their products to market and helps clients navigate the complexities of market access in the UK and Europe. Our cross-functional team has completed over 200 successful HTA submissions, drawing on profound expertise from diverse sectors including industry, HTA and payer organisations, healthcare, academia and consultancy.

Aligning regulatory and reimbursement activities is critical to the success of providing access to patients. Early engagement can make a significant impact on successful patient access

Early Engagement

Assess the appropriateness of clinical trials for the UK and European markets
Early economic modelling
Target Product Profile testing
Review comparators and Health-Related Quality of Life inputs and outputs
Engage with clinicians to confirm treatment pathways and product positioning
Facilitate early dialogue with payers and Patient Advocacy Groups
Organise and run advisory boards and Delphi panels of Key Opinion Leaders
Support marketing strategy
Develop the UK and European value propositions
Advise and support pricing strategy

Determining the right market access and pricing strategy is essential to maximise revenue and accelerate patient access

Market Access & Pricing Strategy

Develop market access strategies based on over 200+ successful products brought to market
Develop your optimum evidence package by providing early insights and strategy
With launch sequencing through international reference pricing
Obtain payer and stakeholder insights into the perceived value of your product
Understand payer evidence requirements to support reimbursement
Test the willingness to pay through payer research
With commercial access pricing support to enhance reimbursement

HEOR plays a critical role in building the evidence package required to support reimbursement. One of the most impactful use of HEOR modelling is as a strategic planning tool to consider data gaps and value profiling early in a product's lifecycle, influencing global evidence generation for reimbursement

Health Economics &
Outcomes Research

Cost effectiveness and budget impact modelling
Early model review
Disease area and payer landscape insights research
Evidence gap analysis and mitigation plans
Treatment pathway and model input validation
KOL engagement advisory boards
Evidence generation support
Stakeholder engagement and payer negotiations
Guidance on pricing strategies
HTA modelling
Building models for you from scratch or repurposing existing models

We can help influence the access landscape for your company or product, while creating shared alignment with your stakeholders. MAP’s health policy and stakeholder communications experts will address potential challenges, mitigate risks and optimise opportunities across the political and healthcare ecosystem to support patient access 

Policy & Public Affairs

Strategic planning, positioning and message development
Political, economic, social and technological analysis to help strategic and operational business planning
Bespoke policy analysis to identify opportunities and risks, advisory boards to provide clinical and stakeholder insights
Tailored monitoring of policy and stakeholder developments
Influencing policy through reports, consultation responses and briefings
Evidence-based thought leadership and collaborative policy development
Stakeholder mapping and prioritisation based on relevance and influence
Stakeholder engagement, political and media communications
Organising and attending roundtables, seminars, conferences and parliamentary events
Policy and Public Affairs training

Our team has extensive experience in producing clear, concise and impactful materials that are tailored to your specific communication objectives. With expertise in all the major therapeutic areas our highly trained team will convey the right messages, in the right way, to the right audience  bringing your data to life

Value Communication

PIM and EAMS applications
Value propositions
Global value dossiers
Systematic literature reviews
HTA and reimbursement submissions
Study reports
Delphi panels to achieve consensus on issues contributing to submissions
Stakeholder communication tools
Publications

MAP’s experienced team can identify and address legal pitfalls in the market access environment. We provide proactive and solution-orientated legal support

Legal Counsel

Strategic contract review services with the aim of protecting clients’ interests
Counselling key stakeholders to ensure compliance with relevant national and international healthcare laws, regulations, and guidance
Strategic legal support during the process of NICE and other Market Access submissions across the UK and Europe
Partnering with MAP internal functions to ensure a holistic approach to clients’ Market Access needs while assessing and mitigating compliance risks
Leveraging knowledge of emerging legal and industry issues and trends to inform bespoke legal support
Ensuring in-house compliance to regulatory codes by providing training and guidance

Why us?

Rich Expertise: With over 300 years of combined experience across European markets, our team brings profound expertise from diverse sectors including industry, HTA and payer organisations, healthcare, academia, and consultancy.
Matrix Approach: We tackle challenges from multiple perspectives, ensuring a holistic view by involving various functions in the decision-making process, thus connecting all the dots.
Joined-up Services: Our comprehensive services cover the entire product lifecycle, from regulatory application to reimbursement, ensuring seamless support at every stage.
Power of our Network: Our extensive network, encompassing a wide range of stakeholders, grants us access to insights informing an optimal market access launch in Europe.
Tailored Approach: We offer expert consultancy paired with digital solutions, customised to your unique circumstances, to help get your products from the lab to patients as smoothly and quickly as possible.

Let’s have a chat.

We pride ourselves to have a personal relationship with our network of stakeholders, opinion leaders and clients, and we would love to get to know you as well. Feel free to reach out for a chat.

Meet MAP Patient Access